Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2009-01-29 to 2009-02-24
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
, 2008
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
, adopted 1987-02-24
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl (ethylcarbamoyl)formate
EC Number:
700-185-4
Cas Number:
1122460-01-8
Molecular formula:
C14H25NO3
IUPAC Name:
(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl (ethylcarbamoyl)formate
Test material form:
liquid: viscous
Details on test material:
- EC name: Acetic-acid, 2- (ethylamino) -2-oxo, (1R,2S,5R) -5-methyl- 2- (1-methylethyl)- cyclohexyl ester
- Molecular formula: C14H25NO3
- Molecular weight: 255.36g/mol
- Physical state: liquid, colourless, viscous oil
- Storage condition of test material: room temperature

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- SPF Wistar rats of the stock Crl:WI
- Source: Charles River Deutschland GmbH, 97633 Sulzfeld, Germany
- Weight at study initiation: 200 - 228 g; pilot study: 216 g
- Fasting period before study: the rats were not fasted prior dosing.
- Housing: the rats were kept in transparent macrolone cages (type 3-180, floor area 810 sq.cm) with two or three in each cage, males and females separated. The cages were cleaned and the bedding changed at least twice a week. Bedding was "Lignocel-Fasern" from Altromin, 32791 Lage, Germany.
- Diet (ad libitum): complete rodent diet "Altromin 1314" from Altromin, 32791 Lage, Germany.
- Water (ad libitum): domestic quality drinking water wtih hydrochloric acid to pH 2.5.
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 30 to 70 %
- Air changes: 10 times / hour
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: On the day before the application of the test item the hair was removed from the back and flanks with an electric clipper. On day = the tet item was applied to the prepared skin area of 6x8 cm.
- Type of wrap if used: 4-layer gauze pack, the gauze packs were fixed with Microtape wound around the trunk.

REMOVAL OF TEST SUBSTANCE
- Washing: mild soap and luke warm water
- Time after start of exposure: 24 h

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw. (sighting study / main study)
Duration of exposure:
24 hours
Doses:
2000 mg/kg bw. (sighting study / main study)
No. of animals per sex per dose:
sighting study: one female (2000 mg/kg bw.)
main study: five female / five males (2000 mg/kg bw.)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: each rat was observed 1, 3 and 6 hours after the start of dosing and thereafter daily for a period of 14 consecutive days. Body weight was recorded on days 0, 7 and 6 hours after the start of dosing and thereafter daily for a period of 14 consecutive days.
- Necropsy of survivors performed: yes; alle rats were killed by inhalation of CO2 on day 14 and subjected to a gross necropsy examination
Statistics:
not applicable

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
There were no deaths.
Clinical signs:
other: PILOT STUDY The animal included in the pilot study appeared apathetic on day 0 after 1 hour, 3 hours and 6 hours. From day 1 to the end of the observation period on day 14 no abnormalities were revealed. MAIN STUDY The animals included in the main study
Gross pathology:
PILOT STUDY
The post mortem inspection revealed no pathological abnormalities.
MAIN STUDY
The post mortem inspection revealed no pathological abnormalities.
Other findings:
Dermal reactions: there were no signs of dermal irritation.

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The acute dermal median lethal dose (LD50) of the test material in the SPF Wistar rats of the stock Crl:Wl was found to be greater than 2000 mg/kg bodyweight.
According to the EC-Commission directive 67/548/EEC and its subsequent amendments, the test substance is not classified as acute toxic via the dermal route.
According to the EC-Regulation 1272/2008 and subsequent regulations, the test item is not classified as acute toxic via the dermal route.